首页> 外文期刊>Journal of Materials Science >Micronization of sulfamethoxazole using the supercritical anti-solvent process
【24h】

Micronization of sulfamethoxazole using the supercritical anti-solvent process

机译:使用超临界反溶剂法将磺胺甲恶唑微粉化

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

Micronization of an antibiotic compound sulfamethoxazole was investigated in this study using the supercritical anti-solvent (SAS) precipitation method. The results from either the batch or continuous process were compared, and the latter one yielded smaller particles. Effects on particle size due to various process parameters in the continuous SAS process (the concentration and the flow rate of the solution of sulfamethoxazole, the operating pressure and temperature) had been studied through a fractional factorial design for sulfamethoxazole. The experimental results showed that there was a significant interaction between the parameters of the flow rate and the concentration of the sulfamethoxazole solution. Analyses of the micronized sulfamethoxazole particles were examined using SEM, XRD and DSC. Sulfamethoxazole was micronized from its original size of 41.7 to 5.1 mu m. The micronized sulfamethoxazole exhibited a higher dissolution rate in a simulated intestinal fluid than that of the original compound. It was further demonstrated that the co-precipitation of sulfamethoxazole with a hydrophilic polymer hydroxypropyl cellulose (HPC) in the continuous SAS process provided more enhanced dissolution rate.
机译:在这项研究中,使用超临界抗溶剂(SAS)沉淀法研究了抗生素化合物磺胺甲恶唑的微粉化。比较了分批或连续过程的结果,后一种过程产生了较小的颗粒。通过分次因子设计法研究了连续SAS工艺中各种工艺参数对颗粒尺寸的影响(磺胺甲恶唑溶液的浓度和流速,操作压力和温度)。实验结果表明,流速参数与磺胺甲恶唑溶液的浓度之间存在显着的相互作用。使用SEM,XRD和DSC检查了微粉化的磺胺甲恶唑颗粒的分析。将磺胺甲恶唑从原来的41.7微米微粉化至5.1微米。与原始化合物相比,微粉状磺胺甲基异恶唑在模拟肠液中的溶解速率更高。进一步证明,在连续SAS工艺中,磺胺甲恶唑与亲水性聚合物羟丙基纤维素(HPC)的共沉淀提供了更高的溶解速率。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号